Sensory-nerve-derived neuropeptides: Possible therapeutic targets

Handbook of Experimental Pharmacology

Volumn 194, Issue , 2009, Pages 393-416

  Fernandes, Elizabeth S ^a   Schmidhuber, Sabine M ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CGRP; Galanin; Neuropeptides; Substance p

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CAPSAICIN; FK 224; G PROTEIN COUPLED RECEPTOR; GALANIN; L 7030606; LANEPITANT; MK 0974; NEUROPEPTIDE; NEUROTRANSMITTER; OLCEGEPANT; SPANTIDE; SPANTIDE II; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; AUTACOID;

ARTHRALGIA; ARTHRITIS; ASTHMA; CANCER THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL TRACT; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INNERVATION; MICROVASCULATURE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS; SENSORY NERVE; SEPSIS; SIGNAL TRANSDUCTION; SKIN DISEASE; UNSPECIFIED SIDE EFFECT; VASODILATATION; ANIMAL; DRUG EFFECT; INFLAMMATION; METABOLISM; NEURALGIA; SENSORY RECEPTOR;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCITONIN GENE-RELATED PEPTIDE; GALANIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEURALGIA; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION; SUBSTANCE P; TACHYKININS;

EID: 70349907770     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-79090-7_11     Document Type: Review

References (158)

1. Ahmed M, Bjurholm A, Srinivasan GR, Lundeberg T, Theodorsson E, Schultzberg M, Kreicbergs A (1995) Capsaicin effects on substance P and CGRP in rat adjuvant arthritis. Regul Pept 55:85-102
2. Ahren B, Wierup N, Sundler F (2006) Neuropeptides and the regulation of islet function. Diabetes 55(Suppl 2):S98-S107
3. Ahrens B, Lindskog S (1992) Galanin and the regulation of islet hormone secretion. Int J Pancreatol 1:147-160
4. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ (1995) Neuropeptides and general neuronal marker in psoriasis - an immunohistochemical study. Clin Exp Dermatol 20:384-389
5. Ansel JC, Brown JR, Payan DG, Brown MA (1993) Substance P selectively activates TNF-a gene expression in murine mast cells. J Immunol 150:4478-4485
6. Bartfai T, Hokfelt T, Langel U (1993) Galanin - a neuroendocrine peptide. Crit Rev Neurobiol 7:229-274
7. Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR (1989) Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 97:260-264
8. Bayliss WM (1901) On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb, and on the nature of these fibres. J Physiol 26:173-209
9. Beer S, Weighardt H, Emmanuilidis K, Harzenetter MD, Matevossian E, Heidecke CD, Bartels H, Siewert JR, Holzmann B (2002) Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 30:1794-1798
10. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CS, Yeats JC (1992) Capsazepine: A competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 107:544-552
11. Bienenstock J, Tomioka M, Matsuda H, Stead RH, Quinonez G, Simon GT, Coughlin MD, Denburg JA (1987) The role of mast cells in inflammatory processes: evidence for nerve/ mast cell interactions. Int Arch Allergy Appl Immunol 82:238-243
12. Blum AM, Metwali A, Cook G, Mathew RC, Elliott D, Weinstock JV (1993) Substance P modulates antigen-induced, IFN-gamma production in murine Schistosomiasis mansoni. J Immunol 151:225-233
13. Blum AM, Metwali A, Kim-Miller M, Li J, Qadir K, Elliott DE, Lu B, Fabry Z, Gerard N, Weinstock JV (1999) The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni. J Immunol 162:6080-6085
14. Botella A, Delvaux M, Bueno L, Frexinos J (1992) Intracellular pathways triggered by galanin to induce contraction of pig ileum smooth muscle cells. J Physiol 458:475-486
15. Brain SD, Cox HM (2006) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147(Suppl 1):S202-S211
16. Brain SD, Grant AD (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903-934
17. Brain SD, Williams TJ (1985) Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 86:855-860
18. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54-56
19. Brodish RJ, Kuvshinoff BW, Fink AS, McFadden DW (1994) Inhibition of pancreatic exocrine secretion by galanin. Pancreas 9:297-303
20. Brown DR, Hildebrand KR, Parsons AM, Soldani G (1990) Effects of galanin on smooth muscle and mucosa of porcine jejunum. Peptides 11:497-500
21. Buck SH (1988) Multiple receptors for the tachykinin peptides. Proc West Pharmacol Soc 31: 45-47
22. Bulling DG, Kelly D, Bond S, McQueen DS, Seckl JR (2001) Adjuvant-induced joint inflammation causes very rapid transcription of beta-preprotachykinin and alpha-CGRP genes in innervating sensory ganglia. J Neurochem 77:372-382
23. Burgevin MC, Loquet I, Quarteronet D, Habert-Ortoli E (1995) Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J Mol Neurosci 6:33-41
24. Campos MM, Calixto JB (2000) Neurokinin mediation of edema and inflammation. Neuropeptides 34:314-322
25. Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O'Keane JC, Jaffer A, Theoharides TC, Pothoulakis C (1994) Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107:657-665
26. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816-824
27. Chahl LA (2004) Hydrogen sulphide: An endogenous stimulant of capsaicin-sensitive primary afferent neurons? Br J Pharmacol 142:1-2
28. Chan J, Smoller BR, Raychauduri SP, Jiang WY, Farber EM (1997) Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 289:611-616
29. Chan-Palay V (1988) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 273:543-557
30. Chawla SP, Grunberg SM, Gralla RJ et al (2003) Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer 97: 2290-2300
31. Clark N, Keeble J, Fernandes ES, Starr A, Liang L, Sugden D, de Winter P, Brain SD (2007) The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J 21:3747-3755
32. Courtice GP, Hales JR, Potter EK (1994) Selective regional vasoconstriction underlying pressor effects of galanin in anaesthetized possums compared with cats. J Physiol 481:439-445
33. Crawley JN (1999) The role of galanin in feeding behavior. Neuropeptides 33:369-375
34. Cunningham MJ (2004) Galanin-like peptide as a link between metabolism and reproduction. J Neuroendocrinol 16:717-723
35. Dagar S, Onyüksel H, Akhter S, Krishnadas A, Rubinstein I (2003) Human galanin expresses amphipathic properties that modulate its vasoreactivity in vivo. Peptides 24:1373-1380
36. Delvaux M, Botella A, Fioramonti J, Frexinos J, Bueno L (1991) Galanin induces contraction of isolated cells from circular muscle layer of pig ileum. Regul Pept 32:369-374
37. Diz DI, Jessup JA, Westwood BM, Bosch SM, Vinsant S, Gallagher PE, Averill DB (2002) Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin Exp Pharmacol Physiol 29:473-482
38. Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, Eberlein W (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420-423
39. Doods H, Arndt K, Rudolf K (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580-587
40. Dzurik MV, Diedrich A, Black B, Paranjape SY, Raj SR, Byrne DW, Robertson D (2007) Endogenous substance P modulates human cardiovascular regulation at rest and during orthostatic load. J Appl Physiol 102:2092-2097
41. Elliott-Hunt CR, Marsh B, Bacon A, Pope R, Vanderplank P, Wynick D (2004) Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci USA 101:5105-5110
42. Evans HF, Shine J (1991) Human galanin: Molecular cloning reveals a unique structur. Endocrinology 129:1682-1684
43. Eysselein VE, Nast CC (1991) Neuropeptides and inflammatory bowel disease. Z Gastroenterol Verh 26:253-257
44. Fathi Z, Battaglino PM, Iben LG et al (1998) Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor. Brain Res Mol Brain Res 58:156-169
45. Feistritzer C, Clausen J, Sturn DH, Djanani A, Gunsilius E, Wiedermann CJ, Kähler CM (2003) Natural killer cell functions mediated by the neuropeptide substance P. Regul Pept 116:119-126
46. Ferrell WR, Lockhart JC, Karimian SM (1997) Tachykinin regulation of basal synovial blood flow. Br J Pharmacol 121:29-34
47. Flatters SJ, Fox AJ, Dickenson A (2002) Nerve injury induces plasticity that results in spinal inhibitory effects of galanin. Pain 98:249-258
48. Flowe KM, Lally KM, MulhollandMW (1992) Galanin inhibits rat pancreatic amylase release via cholinergic suppression. Peptides 13:487-492
49. Foreman JC, Jordan CC, Piotrowski W (1983) Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. 77:531-539
50. Foster AP, Cunningham FM (2003) Substance P induces activation, adherence and migration of equine eosinophils. J Vet Pharmacol Ther 26:131-138
51. Fraley GS, Thomas-Smith SE, Acohido BV, Steiner RA, Clifton DK (2004) Stimulation of sexual behavior in the male rat by galanin-like peptide. Horm Behav 46:551-557
52. Garrett NE, Kidd BL, Cruwys SC, Tomlinson DR (1995) Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: comparison with changes in synovial substance P levels. Brain Res 675:203-207
53. Germonpré PR, Joos GF, Pauwels RA (1995) Characterization of the neurogenic plasma extravasation in the airways. Arch Int Pharmacodyn Ther 329:185-203
54. Goetzl EJ, Chernov T, Renold F, Payan DG (1985) Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135:802s-805s
55. Goldstein DJ, Wang O, Todd LE, Gitter BD, DeBrota DJ, Iyengar S (2000) Study of the analgesic effect of lanepitant in patients with osteoarthritis pain. Clin Pharmacol Ther 67:419-426
56. Gottsch ML, Clifton DK, Steiner RA (2004) Galanin-like peptide as a link in the integration of metabolism and reproduction. Trends Endocrinol Metab 15:215-221
57. Gradl G, Finke B, Schattner S, Gierer P, Mittlmeier T, Vollmar B (2007) Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain. Neuroscience 148:757-765
58. Green PG, Basbaum AI, Levine JD (1992) Sensory neuropeptide interactions in the production of plasma extravasation in the rat. Neuroscience 50:745-749
59. Gross KJ, Pothoulakis C (2007) Role of neuropeptides in inflammatory bowel disease. Inflamm Bowel Dis 13:918-932
60. Gundlach AL (2002) Galanin/GALP and galanin receptors: Role in central control of feeding, body weight/obesity and reproduction? Eur J Pharmaol 440:255-268
61. Hao JX, Shi TJ, Xu IS, Kaupilla T, Xu XJ, Hökfelt T, Bartfai T, Wiesenfeld-Hallin Z (1999) Intrathecal galanin alleviates allodynia-like behaviour in rats after partial peripheral nerve injury. Eur J Neurosci 11:427-432
62. Herzig KH, Brunke G, Schön I, Schäffer M, Fölsch UR (1993) Mechanism of galanin's inhibitory action on pancreatic enzyme secretion: Modulation of cholinergic transmission-studies in vivo and in vitro. Gut 34:1616-1621
63. Hökfelt T, Wiesenfeld-Hallin Z, Villar M, Melander T (1987) Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett 83:217-220
64. Holmes FE, Mahoney S, King VR, Bacon A, Kerr NC, Pachnis V, Curtis R, Priestley JV, Wynick D (2000) Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc Natl Acad Sci USA 97:1563-11568
65. Holmes FE, Mahoney SA, Wynick D (2005) Use of genetically engineered transgenic mice to investigate the role of galanin in the peripheral nervous system after injury. Neuropeptides 39:191-199
66. Holzer P (1998) Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30:5-11 (Pubitemid 27497213)
67. Holzer-Petsche U (1995) Tachykinin receptors in gastrointestinal motility. Regul Pept 57:19-42
68. Hong SK, Han JS, Min SS, Hwang JM, Kim YI, Na HS, Yoon YW, Han HC (2002) Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat. Neurosci Lett 322:21-24
69. Ikeda Y, Takei H, Matsumoto C, Mase A, Yamamoto M, Takeda S, Ishige A, Watanabe K (2007) Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Arch Dermatol Res 299:345-351
70. Iwasaki A, Inoue K, Hukuda S (1995) Distribution of neuropeptide- containing nerve fibers in the synovium and adjacent bone of the rat knee joint. Clin Exp Rheumatol 13:173-178
71. Jancsó N, Jancsó-Gabor A, Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 31:138-151
72. Jancsó G, Kiraly E, Jancsó-Gabor A (1977) Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 270:741-743
73. Jancsó G, Sántha P, Horváth V, Pierau F (2000) Inhibitory neurogenic modulation of histamineinduced cutaneous plasma extravasation in the pigeon. Regul Pept 95:75-80
74. Jeanjean AP, Moussaoui SM, Maloteaux JM, Laduron PM (1995) Interleukin-1b induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 68:151-157
75. Ji RR, Zhang X, Zhang Q, Dagerlind A, Nilsson S, Wiesenfeld-Hallin Z, Hökfelt T (1995) Central and peripheral expression of galanin in response to inflammation. Neuroscience 68:563-576
76. Jiang WY, Raychaudhuri SP, Farber EM (1998) Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 37:572-574
77. Joos GF, Kips JC, Peleman RA, Pauwels RA (1995) Tachykinin antagonists and the airways. Arch Int Pharmacodyn Ther 329:205-219
78. Juréus A, Cunningham MJ, Li D, Johnson LL, Krasnow SM, Teklemichael DN, Clifton DK, Steiner RA (2001) Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse. Endocrinology 142:5140-5144
79. Kähler CM, Sitte BA, Reinisch N, Wiedermann CJ (1993) Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol 249:281-286 (Pubitemid 23334101)
80. Kar S, Rees RG, Quirion R (1994) Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyarthritic rat. Eur J Neurosci 6:345-354
81. Keeble JE, Brain SD (2004) A role for substance P in arthritis? Neurosci Lett 361:176-179
82. Kerr BJ, Cafferty WB, Gupta YK, Bacon A, Wynick D, McMahon SB, Thompson SW (2000) Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury. Eur J Neurosci 12:793-802
83. Kerr BJ, Gupta Y, Pope R, Thompson SW, Wynick D, McMahon SB (2001) Endogenous galanin potentiates spinal nociceptive processing following inflammation. Pain 93:267-277
84. Khan WI, Collins SM (2004) Immune-mediated alteration in gut physiology and its role in host defence in nematode infection. Parasite Immunol 26:319-326
85. Khawaja AM, Rogers DF (1996) Tachykinins: receptor to effector. Int J Biochem Cell Biol 28:721-738
86. Kincy-Cain T, Bost KL (1996) Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J Immunol 157:255-264
87. Kinney JW, Starosta G, Holmes A, Wrenn CC, Yang RJ, Harris AP, Long KC, Crawley JN (2002) Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem 9:178-190
88. Kisfalvi I Jr, Burghardt B, Bálint A, Zelles T, Vizi ES, Varga G (2000) Antisecretory effects of galanin and its putative antagonists M15, M35 and C7 in the rat stomach. J Physiol Paris 94:37-42
89. Kolakowski LF, O'Neill GP, Howard AD et al (1998) Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem 71:2239-2251
90. Konttinen YT, Hukkanen M, Segerberg M, Rees R, Kemppinen P, Sorsa T, Saari H, Polak JM, Santavirta S (1992) Relationship between neuropeptide immunoreactive nerves and inflammatory cells in adjuvant arthritic rats. Scand J Rheumatol 21:55-59
91. Koon HW, Pothoulakis C (2006) Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann N Y Acad Sci 1088:23-40
92. Kramer MS, Winokur A, Kelsey J et al (2004) Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology 29:385-392
93. Krasnow SM, Fraley GS, Schuh SM, Baumgartner JW, Clifton DK, Steiner RA (2003) A role of galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse. Endocrinology 144:813-822
94. Lam FY, Wong MC (1996) Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat. Br J Pharmacol 118:2107-2114
95. Lam FY, Ferrell WR, Scott DT (1993) Substance P-induced inflammation in the rat knee joint is mediated by neurokinin 1 (NK1) receptors. Regul Pept 46:198-201
96. Landry M, Roche D, Vila-Porcile E, Calas A (2000) Effects of centrally administered galanin (1-16) on galanin expression in the rat hypothalamus. Peptides 21:1725-1733
97. Landry M, Liu HX, Shi TJ, Brumovsky P, Nagy F, Hökfelt T (2005) Galaninergic mechanisms at the spinal level: focus on histochemical phenotyping. Neuropeptides 39:223-231
98. Lang R, Gundlach AL, Kofler B (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 115:177-207
99. Larm JA, Gundlach AL (2000) Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain. Neuroendocrinology 72:67-71
100. Lecci A, Capriati A, Maggi CA (2004) Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br J Pharmacol 141:1249-1263
101. Lewis T, Zotterman Y (1927) Vascular reactions of the skin to injury: part VIII. The resistance of the human skin to constant currents, in relation to injury and vascular response. J Physiol 62:280-288
102. Lindsey KQ, Caughman SW, Olerud JE, Bunnett NW, Armstrong CA, Ansel JC (2000) Neural regulation of endothelial cell-mediated inflammation. J Investig Dermatol Symp Proc 5:74-78
103. Liu H, Hockfelt T (2002) The participation of galanin in pain processing at the spinal level. Trends Pharmacol Sci 23:468-474
104. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hökfelt T (2001) Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: Selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA 98:9960-9964
105. Maggi CA (1995) The mammalian tachykinin receptors. Gen Pharmacol 26:911-944
106. Maggi CA (1997) Tachykinins as peripheral modulators of primary afferent nerves and visceral sensitivity. Pharmacol Res 36:153-169
107. Mahoney SA, Hosking R, Farrant S, Holmes FE, Jacoby AS, Shine J, Iismaa TP, Scott MK, Schmidt R, Wynick D (2003) The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons. J Neurosci 23:416-421
108. Matsumoto Y, Watanabe T, Adachi Y, Itoh T, Ohtaki T, Onda H, Kurokawa T, Nishimura O, Fujino M (2002) Galanin-like peptide stimulates food intake in the rat. Neurosci Lett 322:67-69
109. Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T (2004) Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci 19:3235-3244
110. McDonald AC, Schuijers JA, Shen PJ, Gundlach AL, Grills BL (2003) Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat. Bone 33:788-797
111. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
112. Mufson EJ, Cochran E, Benzing W, Kordower JH (1993) Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging. Alzheimer's disease and Down's syndrome. Dementia 4:237-250
113. Mulholland MW, Schoeneich S, Flowe K (1992) Galanin inhibition of enteric cholinergic neurotransmission: Guanosine triphosphate-binding protein interactions with adenylate cyclase. Surgery 112:195-201
114. Mungan Z, Ozmen V, Ertan A, Coy DH, Baylor LM, Rice JC, Rossowski WJ (1992) Structural requirements for galanin inhibition of pentagastrin-stimulated gastric acid secretion in conscious rats. Eur J Pharmacol 214:53-57
115. Mussap CJ, Geraghty DP, Burcher E (1993) Tachykinin receptors: A radioligand binding perspective. J Neurochem 60:1987-2009
116. Neil GA, Blum A, Weinstock JV (1991) Substance P but not vasoactive intestinal peptide modulates immunoglobulin secretion in murine schistosomiasis. Cell Immunol 135:394-401
117. Nilsson J, von Euler AM, Dalsgaard CJ (1985) Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:61-63
118. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110
119. Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Hunt SP, Klapp BF, Arck PC, Peters EM (2008) Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 128:434-446
120. Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE (2006) Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 126:1937-1947
121. Pincelli C, Fantini F, Romualdi P, Sevignani C, Lesa G, Benassi L, Giannetti A (1992) Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 98:421-427
122. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider RM, Leeman SE (1994) CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci USA 91:947-951
123. Potter EK, Smith-White MA (2005) Galanin modulates cholinergic neurotransmission in the heart. Neuropeptides 39:345-348
124. Puneet P, Hegde A, Ng SW, Lau HY, Lu J, Moochhala SM, Bhatia M (2006) Preprotachykinin- A gene products are key mediators of lung injury in polymicrobial sepsis. J Immunol 176:3813-3820
125. Regoli D, Boudon A, Fauchere JL (1994) Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46:551-599
126. Richardson JD, Vasko MR (2002) Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302:839-845
127. Rossmanith WG, Clifton DK, Steiner RA (1996) Galanin gene expression in hypothalamic GnRHcontaining neurons in the rat: A model for autocrine regulation. Horm Metab 28:257-266
128. Salvatore C, Hershey J, Corcoran H et al (2008) Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2- trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3- dihydro-1H-imidazo[4,5-b]pyridin-1-yl) piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 324:416-421
129. Sanger GJ (2004) Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain. Br J Pharmacol 141:1303-1312
130. Santic R, Fenninger K, Graf K et al (2006) Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. J Mol Neurosci 29:145-152
131. Saraceno R, Kleyn CE, Terenghi G, Griffiths CE (2006) The role of neuropeptides in psoriasis. Br J Dermatol 155:876-882
132. Sarnelli G, Vanden Berghe P, Raeymaekers P, Janssens J, Tack J (2004) Inhibitory effects of galanin on evoked [Ca2+]i responses in cultured myenteric neurons. Am J Physiol Gastrointest Liver Physiol 286:G1009-G1014
133. Schepp W, Prinz C, Tatge C, Ha°kanson R, Schusdziarra V, Classen M (1990) Galanin inhibits gastrin release from isolated rat gastric G-cells. Am J Physiol 258:G596-G602 (Pubitemid 20144081)
134. Schmidhuber SM, Santic R, Tam CW, Bauer JW, Kofler B, Brain SD (2007) Galanin-like peptides exert potent vasoactive functions in vivo. J Invest Dermatol 127:716-721
135. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81-96
136. Shen PJ, Larm JA, Gundlach AL (2003) Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones in normal brain and after spreading depression. Eur J Neurosci 18:1362-1376
137. Shepherd AJ, Beresford LJ, Bell EB, Miyan JA (2005) Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P. J Neuroimmunol 164:115-123
138. Sluka KA, Westlund KN (1993) Behavioral and immunohistochemical changes in an experimental arthritis model in rats. Pain 55:367-377
139. Sluka KA, Milton MA, Willis WD, Westlund KN (1997) Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol 120:1263-1273
140. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J (1987) Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 84:2975-2979
141. Steinhoff M, Ständer S, Seeliger S, Ansel JC, Schmelz M, Luger T (2003) Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 139:1479-1488
142. Storer RJ, Akerman S, Goadsby PJ (2004) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142:1171-1181
143. Takatsu Y, Matsumoto H, Ohtaki T, Kumano S, Kitada C, Onda H, Nishimura O, FujinoM (2001) Distribution of galanin-like peptide in the rat brain. Endocrinology 142:1626-1634
144. Talero E, Sánchez-Fidalgo S, Ramón Calvo J, Motilva V (2006) Galanin in the trinitrobenzene sulfonic acid rat model of experimental colitis. Int Immunopharmacol 6:1404-1412
145. Talero E, Sánchez-Fidalgo S, Calvo JR, Motilva V (2007) Chronic administration of galanin attenuates the TNBS-induced colitis in rats. Regul Pept 141:96-104
146. Tanaka T, Danno K, Ikai K, Imamura S (1988) Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 90:399-401
147. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 164:124-128
148. Umer A, Ugowska H, Sein-Anand J, Rekowski P, Ruczyński J, Petrusewicz J, Korolkiewicz RP (2005) The contractile effects of several substituted short analogues of porcine galanin in isolated rat jejunal and colonic smooth muscle strips. Pharmacol Res 52:283-289
149. Vachon P, Masse R, Gibbs BF (2004) Substance P and neurotensin are up-regulated in the lumbar spinal cord of animals with neuropathic pain. Can J Vet Res 68:86-92
150. Viac J, Gueniche A, Doutremepuich JD, Reichert U, Claudy A, Schmitt D (1996) Substance P and keratinocyte activation markers: An in vitro approach. Arch Dermatol Res 288:85-90
151. Von Euler US, Gaddum JH (1931) An unidentified depressor substance in certain tissue extracts. J Physiol 72:74-87
152. Walsh DA, McWilliams F (2006) Tachykinins and the cardiovascular system. Curr Drug Targets 7:1031-1042
153. Weber M, Birklein F, Neundörfer B, Schmelz M (2001) Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 91:251-257 (Pubitemid 32241145)
154. Woodbury RG, Miller HR, Huntley JF, Newlands GF, Palliser AC, Wakelin D (1984) Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature 312:450-452
155. Xu XJ, Hao JX, Wiesenfeld-Hallin Z, Ha°kanson R, Folkers K, Hökfelt T (1991) Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw. Neuroscience 42:731-737
156. Xu XJ, Hökfelt T, Bartfai T, Wiesenfeld-Hallin Z (2000) Galanin and spinal nociceptive mechanisms: Recent advances and therapeutic implications. Neuropeptides 34:137-147
157. Yau WM, Dorsett JA, Youther ML (1986) Evidence for galanin as an inhibitory neuropeptide on myenteric cholinergic neurons in the guinea pig small intestine. Neurosci Lett 72:305-308
158. Zhang H, Hegde A, Ng SW, Adhikari S, Moochhala SM, Bhatia M (2007) Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury. J Immunol 179:4153-4160